Vulnerability record · CVE-2017-12721 · published 15 February 2018
CVE-2017-12721: Smiths-medical medfusion 4000 wireless syringe infusion pump improper certificate validation vulnerability
SSmiths Medical · Medfusion 4000 Wireless Syringe Infusion Pump
An Improper Certificate Validation issue was discovered in Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump, Version 1.1, 1.5, and 1.6. The pump does not validate host certificates, leaving the pump vulnerable to a man-in-the-middle (MITM) attack.
Description
An Improper Certificate Validation issue was discovered in Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump, Version 1.1, 1.5, and 1.6. The pump does not validate host certificates, leaving the pump vulnerable to a man-in-the-middle (MITM) attack.
CVSS:3.0/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N
Affected products
1 vulnerable configurations from NVD's CPE data, grouped by vendor and product.
References
| Link | Tags |
|---|---|
| http://www.securityfocus.com/bid/100665 | Third Party AdvisoryVDB Entry |
| https://ics-cert.us-cert.gov/advisories/ICSMA-17-250-02A | Third Party AdvisoryUS Government Resource |
| http://www.securityfocus.com/bid/100665 | Third Party AdvisoryVDB Entry |
| https://ics-cert.us-cert.gov/advisories/ICSMA-17-250-02A | Third Party AdvisoryUS Government Resource |
Track CVE-2017-12721 inside VULONE
Watch it alongside the ransomware crews, C2 infrastructure and forum chatter that reference it, query it through the API and pull it into your SIEM over TAXII.
Related vulnerabilities
Same products first, then exploited flaws of the same weakness class.
Source: NIST National Vulnerability Database (record CVE-2017-12721), CISA KEV, FIRST EPSS (scores of 2026-09-28). This page is refreshed as NVD updates the record.